Integrated molecular characterization of diffuse gliomas: oncogenic signaling networks revealed by combined DNA/RNA NGS

Chiadini, Elisa (2026) Integrated molecular characterization of diffuse gliomas: oncogenic signaling networks revealed by combined DNA/RNA NGS, [Dissertation thesis], Alma Mater Studiorum Università di Bologna. Dottorato di ricerca in Scienze biomediche e neuromotorie, 38 Ciclo. DOI 10.48676/unibo/amsdottorato/13171.
Documenti full-text disponibili:
[thumbnail of Chiadini_Elisa_tesi.pdf] Documento PDF (English) - Richiede un lettore di PDF come Xpdf o Adobe Acrobat Reader
Disponibile con Licenza: Creative Commons: Attribuzione 4.0 (CC BY 4.0) .
Download (2MB)

Abstract

Background The 2021 WHO Classification of Central Nervous System (CNS) tumors established integrated histomolecular diagnosis as the basis for diffuse glioma classification. In this context, comprehensive molecular profiling is essential to define biologically and clinically relevant tumor subgroups. This study aimed to perform an integrated molecular characterization of adult diffuse gliomas using combined DNA/RNA next-generation sequencing (NGS), complemented by MGMT promoter methylation and 1p/19q codeletion analyses. Methods Fifty-four adult CNS tumor samples were analyzed using the Oncomine™ Comprehensive Assay v3, targeting 161 cancer-related genes at both DNA and RNA levels. Molecular findings were integrated with MGMT promoter methylation and 1p/19q codeletion status to refine diagnostic classification and investigate co-occurrence patterns among key molecular alterations. Results IDH mutation status emerged as the primary molecular discriminator, defining biologically distinct glioma subgroups. IDH-mutant tumors showed the expected molecular signatures, including ATRX loss and TP53 alterations in astrocytomas, and concurrent 1p/19q codeletion and TERT promoter mutations in oligodendrogliomas. In contrast, IDH-wildtype diffuse gliomas displayed a recurrent molecular landscape characterized by TERT promoter mutations (64.3%), EGFR alterations (42.9%), and PTEN variants (45.2%). Functional stratification of PTEN variants revealed distinct associations with MGMT promoter methylation and TERT promoter status. Frequent co-occurrence of EGFR and PTEN alterations suggested coordinated dysregulation of the RTK/PI3K/AKT signaling axis, while the high prevalence of TERT promoter mutations supported telomerase activation as a key mechanism sustaining tumor growth. Conclusions Despite substantial genetic heterogeneity, IDH-wildtype gliomas demonstrated convergence toward shared oncogenic pathways involving telomerase activation and RTK/PI3K/AKT signaling. The analysis of PTEN functional classes and their molecular associations provided additional insight into the genomic architecture of these tumors. Overall, integrated DNA/RNA NGS profiling refined histomolecular diagnosis according to WHO CNS 2021 criteria and contributed to a deeper understanding of the biological mechanisms underlying diffuse glioma progression, supporting future pathway-oriented therapeutic strategies.

Abstract
Tipologia del documento
Tesi di dottorato
Autore
Chiadini, Elisa
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
38
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Diffuse gliomas, Next-generation sequencing (NGS), Integrated molecular diagnostics, WHO CNS 2021 classification
DOI
10.48676/unibo/amsdottorato/13171
Data di discussione
8 Luglio 2026
URI

Altri metadati

Statistica sui download

Gestione del documento: Visualizza la tesi

^